---
title: "ZnT8 autoantibodies are common in rheumatoid arthritis and identify synovial lining fibroblasts as"
id: "medrxiv-12-diabetes-related-antibody-signature-highlights-znt8-as-a-novel-antigenic-target"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-12-diabetes-related-antibody-signature-highlights-znt8-as-a-novel-antigenic-target"
content_type: "clinical_feed_article"
specialty: "Rheumatology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.25.26364002v1?rss=1"
published_at: "2026-10-01T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# ZnT8 autoantibodies are common in rheumatoid arthritis and identify synovial lining fibroblasts as
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-12-diabetes-related-antibody-signature-highlights-znt8-as-a-novel-antigenic-target
- **Specialty:** [Rheumatology](https://medichelpline.com/clinical-feed/rheumatology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.25.26364002v1?rss=1)
- **Published At:** 2026-10-01T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This study measured diabetes-related autoantibodies (GAD65ab, IA2ab, **ZnT8ab**) by ELISA in 326 diabetes-free patients with rheumatoid arthritis (260 females, 66 males). - **ZnT8ab** was the dominant diabetes-related antibody, present in 86% of DMab-positive patients; GAD65ab and IA2ab were detected in 26.4% and 7.0% respectively. - DMab production was more frequent among female patients. - ZnT8ab-positive women had higher circulating insulin and higher **HOMA-IR** index, and lower serum levels of IL-6, IFNγ and IL-9 compared with negatives. - Multivariable logistic regression identified BDNF, insulin and **DAS28** as positive predictors of ZnT8ab production. - In mixed interaction models, increasing ZnT8ab levels were inversely associated with RA-specific autoantibodies. - Single-cell and bulk transcriptome analyses linked rising ZnT8ab levels to an activated secretory CD14+ cell type and showed ZnT8 expression in RA **CD4+ T cells** proportional to ZnT8ab levels. - Single-cell synovial tissue transcriptomes identified **ZnT8+ cells** among lubricin-producing lining layer fibroblasts that display a program associated with invasive behaviour, suggesting the synovial lining as an antigenic source. - Ethical approvals were obtained (Swedish Ethical Review Authority Dnr 659-11; local approvals for synovium and cartilage sampling) and transcriptional data are deposited in GEO (GSE201669, GSE201670).
## Clinical Analysis & Structured Key Points
Diabetes related antibody signature highlights ZnT8 as a novel antigenic target in rheumatoid arthritis | medRxiv Skip to main content Diabetes related antibody signature highlights ZnT8 as a novel antigenic target in rheumatoid arthritis View ORCID Profile Malin C Erlandsson , View ORCID Profile Venkataragavan Chandrasekaran , View ORCID Profile Elena Neumann , View ORCID Profile Yuan Zhang , Malak Alsoofi , View ORCID Profile Sofia T Silfversward , View ORCID Profile Cristina Maglio , View ORCID Profile Ulf Mueller-Ladner , View ORCID Profile Rille Pullertis , View ORCID Profile Maria I Bokarewa doi: https://doi.org/10.64898/2026.09.25.26364002 Malin C Erlandsson 1 Gothenburg University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Malin C Erlandsson Venkataragavan Chandrasekaran 1 Gothenburg University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Venkataragavan Chandrasekaran Elena Neumann 2 University Giessen; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Elena Neumann Yuan Zhang 1 Gothenburg University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Yuan Zhang Malak Alsoofi 1 Gothenburg University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sofia T Silfversward 1 Gothenburg University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Sofia T Silfversward Cristina Maglio 1 Gothenburg University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Cristina Maglio Ulf Mueller-Ladner 3 Kerckhoff Klinik; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Ulf Mueller-Ladner Rille Pullertis 4 Goteborg University Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Rille Pullertis Maria I Bokarewa 1 Gothenburg University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Maria I Bokarewa For correspondence: maria.bokarewa{at}rheuma.gu.se Abstract Info/History Metrics Data/Code Preview PDF Abstract Objective: Autoantibodies are central for pathology of rheumatoid arthritis (RA) and diabetes mellitus (DM) carrying high predictive and diagnostic value. Here, we explore the frequency and functional potential of DM-related antibodies (DMab) in RA. Methods: DMab targeting glutamic acid decarboxylase (GAD65ab), tyrosine phosphatase-like islet antigen 2 (IA2ab) and zinc transporter 8 (ZnT8ab) were measured in 326 DM-free RA patients (260 females, 66 males), using specific ELISAs. The DMab profile was analysed in relation to 30 clinical and serological variables. ZnT8+ cells were detailed by a public single-cell transcriptome in RA synovial tissue. Results: DMab production was more frequent in females, dominated by ZnT8ab (86%), followed by GAD65ab (26.4%) and IA2ab (7.0%). DMab-positive patients, and specifically ZnT8ab-positive women, had higher levels of insulin and HOMA-IR index and lower serum IL-6, IFNγ, and IL-9. Multivariable logistic regression estimating ZnT8ab, IA2ab, GAD65ab production revealed that BDNF, insulin and DAS28 were positive predictors of ZnT8ab. Increasing ZnT8ab levels were inversely related to RAab in the mixed interaction model. CD14+ cell transcriptome identified association between an activated secretory cell type and increasing ZnT8ab levels. Additionally, ZnT8ab levels were in direct proportion with ZnT8 production in RA CD4+ T cells. Single-cell transcriptome of RA synovial tissue revealed ZnT8+ cells among the lubricin producing lining layer fibroblasts programmed for invasive behaviour. Conclusion: This study reveals frequent production of ZnT8ab in non-diabetic RA patients and identifies their antigenic target expressed in lining synovial fibroblasts of RA joints. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study was approved by the Swedish Ethical Review Authority (Dnr 659-11) and was conducted in accordance with national regulations and the International Conference on Harmonization Good Clinical Practice requirements, based on the Declaration of Helsinki. All patients provided written informed consent before being subjected to any study-related procedures. The study is registered at Clinical Trials.gov with ID NCT03449589 . Sample collection of the synovium and cartilage was approved by the local ethics committee of Region West Gotaland (Dnr 2022-01977-02) and Justus Liebig University Giessen (66/08_74/05), and all patients gave written informed consent. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability Transcriptional data are available as Fastq-files and processed reads, deposited in Gene Expression Omnibus (GEO) at the National Centre for Biotechnology Information with the accession codes GSE201669 and GSE201670 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM6069226 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE201670 Funder Information Declared vetenskapsrådet , 2017-03025 , 2017-00359 Reumatikerförbundet , R-566961 , R-751351 , R-969562 , R-862061 Region Västra Götaland, https://ror.org/00a4x6777 , ALFGBG-717681 , ALFGBG-965623 , ALFGBG-965012 , ALFGBG-926621 University of Gothenburg, https://ror.org/01tm6cn81 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Back to top Previous Next Posted October 01, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Diabetes related antibody signature highlights ZnT8 as a novel antigenic target in rheumatoid arthritis Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Diabetes related antibody signature highlights ZnT8 as a novel antigenic target in rheumatoid arthritis Malin C Erlandsson , Venkataragavan Chandrasekaran , Elena Neumann , Yuan Zhang , Malak Alsoofi , Sofia T Silfversward , Cristina Maglio , Ulf Mueller-Ladner , Rille Pullertis , Maria I Bokarewa medRxiv 2026.09.25.26364002; doi: https://doi.org/10.64898/2026.09.25.26364002 Share This Article: Copy Citation Tools Diabetes related antibody signature highlights ZnT8 as a novel antigenic target in rheumatoid arthritis Malin C Erlandsson , Venkataragavan Chandrasekaran , Elena Neumann , Yuan Zhang , Malak Alsoofi , Sofia T Silfversward , Cristina Maglio , Ulf Mueller-Ladner , Rille Pullertis , Maria I Bokarewa medRxiv 2026.09.25.26364002; doi: https://doi.org/10.64898/2026.09.25.26364002 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (623) Allergy and Immunology (910) Anesthesia (339) Cardiovascular Medicine (4872) Dentistry and Oral Medicine (483) Dermatology (420) Emergency Medicine (658) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1640) Epidemiology (16040) Forensic Medicine (34) Gastroenterology (1214) Genetic and Genomic Medicine (7115) Geriatric Medicine (735) Health Economics (1072) Health Informatics (5104) Health Policy (1445) Health Systems and Quality Improvement (1788) Hematology (589) HIV/AIDS (1353) Infectious Diseases (except HIV/AIDS) (16347) Intensive Care and Critical Care Medicine (1183) Medical Education (675) Medical Ethics (156) Nephrology (728) Neurology (7364) Nursing (370) Nutrition (1098) Obstetrics and Gynecology (1256) Occupational and Environmental Health (1009) Oncology (3647) Ophthalmology (1064) Orthopedics (399) Otolaryngology (459) Pain Medicine (481) Palliative Medicine (141) Pathology (711) Pediatrics (1821) Pharmacology and Therapeutics (740) Primary Care Research (773) Psychiatry and Clinical Psychology (5965) Public and Global Health (9818) Radiology and Imaging (2455) Rehabilitation Medicine and Physical Therapy (1470) Respiratory Medicine (1255) Rheumatology (648) Sexual and Reproductive Health (781) Sports Medicine (586) Surgery (786) Toxicology (107) Transplantation (310) Urology (296)
## Related Clinical Research

- [SGLT2 Inhibitors and Rheumatoid Arthritis Risk in Type 2 Diabetes: Summary of Reported Emulated Ta](https://medichelpline.com/clinical-feed/frontiers-in-immunology-19-the-association-between-sglt2-inhibitors-and-rheumatoid-arthritis-risk-in-type.md)
- [Resveratrol as an Adjunct to DMARDs in Long-Standing Rheumatoid Arthritis: Effects on Low-Grade In](https://medichelpline.com/clinical-feed/medrxiv-12-complementary-use-of-resveratrol-improves-low-grade-chronic-inflammation.md)
- [Immuno-metabolic Crosstalk in Osteoarthritis: Mechanisms and Therapeutic Insights](https://medichelpline.com/clinical-feed/frontiers-in-immunology-18-immuno-metabolic-crosstalk-in-osteoarthritis-from-mechanisms-to-therapies.md)
- [Endocrine Society Roadmap: Research Priorities and Gaps in Obesity Science](https://medichelpline.com/clinical-feed/endocrine-news-0-endocrine-society-scientific-statement-provides-research-roadmap-for-what-s.md)
- [Lifestyle Changes May Help Prevent Multimorbidity In Prediabetes](https://medichelpline.com/clinical-feed/medical-news-today-23-diet-weight-loss-and-150-minutes-of-exercise-may-protect-against-chronic.md)

## Navigation
- [← Back to Rheumatology Feed](https://medichelpline.com/clinical-feed/rheumatology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.